Literature DB >> 3910726

A study of the renin inhibitor H142 in man.

D J Webb, P J Manhem, S G Ball, G Inglis, B J Leckie, A F Lever, J J Morton, J I Robertson, G D Murray, J Ménard.   

Abstract

The inhibitor of human renin, H142, was studied in nine male volunteers. On three occasions, in random order, volunteers were infused with 5% dextrose or with H142 at 1.0 or 2.5 mg/kg per h for 30 min while supine and thereafter with dextrose for 1 1/2 h. There was a marked reduction in plasma active renin concentration as assayed by an enzyme-kinetic method, with parallel falls in the circulating concentrations of angiotensins (ANG) I and II, all of which rebounded transiently to values above basal after the H142 infusion was stopped. In contrast, total renin concentration as measured by radio-immunoassay rose while ANG I and II fell, subsiding when H142 was discontinued. There was a slight but significant increase in plasma noradrenaline as renin became inhibited; plasma adrenaline was unchanged. H142 produced a slight fall in systolic blood pressure (SBP) and a clearer, highly significant, dose-related fall in diastolic blood pressure (DBP). There was a modest but significant increase in the heart rate. These studies confirm H142 as an effective inhibitor of human renin in vivo.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3910726     DOI: 10.1097/00004872-198512000-00013

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

1.  Pharmacological investigations of a new renin inhibitor in normal sodium-unrestricted volunteers.

Authors:  M de Gasparo; F Cumin; J Nussberger; T T Guyenne; J M Wood; J Menard
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

Review 2.  Renin inhibitors.

Authors:  W J Greenlee
Journal:  Pharm Res       Date:  1987-10       Impact factor: 4.200

Review 3.  Angiotensin converting enzyme inhibitors and moderate hypertension.

Authors:  D McAreavey; J I Robertson
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

4.  Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension.

Authors:  A H van den Meiracker; P J Admiraal; A J Man in 't Veld; F H Derkx; H J Ritsema van Eck; P Mulder; P van Brummelen; M A Schalekamp
Journal:  BMJ       Date:  1990-07-28

Review 5.  Renin inhibitors as possible antihypertensive agents.

Authors:  K G Hofbauer; J M Wood
Journal:  Klin Wochenschr       Date:  1988-09-15

Review 6.  Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.

Authors:  Carlos M Ferrario; Adam E Mullick
Journal:  Pharmacol Res       Date:  2017-05-29       Impact factor: 7.658

Review 7.  Clinical pharmacokinetics and efficacy of renin inhibitors.

Authors:  G A Rongen; J W Lenders; P Smits; T Thien
Journal:  Clin Pharmacokinet       Date:  1995-07       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.